Roldan V - Search Results

1

Reducing bleeding risk in patients on oral anticoagulation therapy.

Soler-Espejo E, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Marín F. Soler-Espejo E, et al. Among authors: roldan v. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):923-936. doi: 10.1080/14779072.2023.2275662. Epub 2023 Dec 13. Expert Rev Cardiovasc Ther. 2023. PMID: 37905915 Review.

2

[The fibrinolytic system in patients with dilated myocardiopathy].

Fernández P, Marín F, Marco P, Roldán V, García MC, Martínez JG, Sogorb F, Calatayud R. Fernández P, et al. Among authors: roldan v. Sangre (Barc). 1996 Oct;41(5):351-5. Sangre (Barc). 1996. PMID: 9026920 Clinical Trial. Spanish.

3

Hypofibrinolysis in atrial fibrillation.

Roldán V, Marín F, Marco P, Martínez JG, Calatayud R, Sogorb F. Roldán V, et al. Am Heart J. 1998 Dec;136(6):956-60. doi: 10.1016/s0002-8703(98)70149-8. Am Heart J. 1998. PMID: 9842006

4

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation.

Marín F, Roldán V, Monmeneu JV, Bodí V, Fernández C, de Burgos FG, Marco P, Sogorb F. Marín F, et al. Among authors: roldan v. Am J Cardiol. 1999 Oct 1;84(7):862-4, A9. doi: 10.1016/s0002-9149(99)00453-1. Am J Cardiol. 1999. PMID: 10513790

5

Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation.

Roldán V, Marín F, Marco P, Climent V, Martínez JG, Monmeneu JV, Bodí V, Garri FS. Roldán V, et al. Haemostasis. 2000 Jul-Aug;30(4):219-24. doi: 10.1159/000054137. Haemostasis. 2000. PMID: 11155040

6

Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction.

Roldán V, Marín F, Fernández P, Luján J, Martínez JG, Pineda J, Marco P, Sogorb F. Roldán V, et al. Int J Cardiol. 2001 Apr;78(2):115-9. doi: 10.1016/s0167-5273(00)00471-x. Int J Cardiol. 2001. PMID: 11334654

7

Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

García A, Marín F, Sánchez B, Roldán V, Marco P. García A, et al. Among authors: roldan v. Stroke. 2002 Jan;33(1):322-4. Stroke. 2002. PMID: 11779936 No abstract available.

8

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients.

González-Conejero R, Corral J, Roldán V, Martínez C, Marín F, Rivera J, Iniesta JA, Lozano ML, Marco P, Vicente V. González-Conejero R, et al. Among authors: roldan v. Blood. 2002 Sep 15;100(6):2081-6. Blood. 2002. PMID: 12200370 Free article.

9

[Hemolytic anemia secondary to paravalvular regurgitation].

Roldán V, Marín F, Climent V. Roldán V, et al. Rev Esp Cardiol. 2002 Sep;55(9):987. doi: 10.1016/s0300-8932(02)76737-7. Rev Esp Cardiol. 2002. PMID: 12236928 Free article. Spanish. No abstract available.

10

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Among authors: roldan v. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page